{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:30:27Z","timestamp":1777901427560,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.iac.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T15:46:00Z","timestamp":1488555960000},"page":"233-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inflammatory Disorders Associated with Allergy"],"prefix":"10.1016","volume":"37","author":[{"given":"Jonathan","family":"Corren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2017.01.001_bib1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","article-title":"63 The multifunctional role of filaggrin in allergic skin disease","volume":"131","author":"McAleer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.iac.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-2275(20)38006-8","article-title":"Human epidermal lipids: characterization and modulations during differentiation","volume":"24","author":"Lampe","year":"1983","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.iac.2017.01.001_bib4","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2017.01.001_bib7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"L-31: a new link between T\u00a0cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.iac.2017.01.001_bib9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-\u03b3 synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2017.01.001_bib10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.iac.2017.01.001_bib11","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A\u00a0role for IL-25 and IL-33\u2013driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2017.01.001_bib12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1081-1206(10)60170-6","article-title":"Expansion of FOXP3-positive CD4+ CD25+ T\u00a0cells associated with disease activity in atopic dermatitis","volume":"103","author":"Ito","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1365-2133.2009.09035.x","article-title":"Regulatory T\u00a0cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion","volume":"160","author":"Szegedi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2017.01.001_bib14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jaci.2004.01.772","article-title":"T\u00a0regulatory cells in atopic dermatitis and subversion of their activity by superantigens","volume":"113","author":"Ou","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Kawakami","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1034\/j.1398-9995.2001.00169.x","article-title":"Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children","volume":"56","author":"Hossny","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2017.01.001_bib17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.01.001_bib18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2017.01.001_bib19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/alr.21002","article-title":"Regulation of murine sinonasal cilia function by microbial secreted factors","volume":"2","author":"Shen","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2017.01.001_bib20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/lary.21921","article-title":"Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium","volume":"121","author":"Blount","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.iac.2017.01.001_bib21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jaci.2013.05.042","article-title":"Regional differences in the expression of innate host defense molecules in sinonasal mucosa","volume":"132","author":"Seshadri","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib22","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1172\/JCI64240","article-title":"T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection","volume":"122","author":"Lee","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iac.2017.01.001_bib23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/alr.21082","article-title":"Clinical severity and epithelial endotypes in chronic rhinosinusitis","volume":"3","author":"Lam","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.iac.2017.01.001_bib24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2017.01.001_bib25","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jaci.2013.12.1092","article-title":"Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity","volume":"133","author":"Mahdavinia","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jaci.2014.08.031","article-title":"Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia","volume":"135","author":"Mahdavinia","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2017.01.001_bib27","doi-asserted-by":"publisher","first-page":"e97581","DOI":"10.1371\/journal.pone.0097581","article-title":"Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps","volume":"9","author":"Derycke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2017.01.001_bib28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jaci.2013.01.043","article-title":"Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression","volume":"131","author":"Hulse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis","volume":"114","author":"Van Zele","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.201207-1292OC","article-title":"Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression","volume":"187","author":"Takabayashi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2017.01.001_bib31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2017.01.001_bib34","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant Th2-like bronchoalveolar T\u00a0lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.01.001_bib36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11882-013-0373-9","article-title":"Role of interleukin-13 in asthma","volume":"13","author":"Corren","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2017.01.001_bib37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/cr.2009.128","article-title":"IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation","volume":"20","author":"Peng","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.iac.2017.01.001_bib38","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T\u00a0cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2017.01.001_bib39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000250438","article-title":"Th17 immunity in patients with allergic asthma","volume":"151","author":"Zhao","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-7-135","article-title":"IL-17 mRNA in sputum of asthmatic patients: linking T\u00a0cell driven inflammation and granulocytic influx?","volume":"7","author":"Bullens","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.iac.2017.01.001_bib41","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.4049\/jimmunol.180.11.7423","article-title":"Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes","volume":"80","author":"Pene","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib42","first-page":"7","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"301","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.iac.2017.01.001_bib43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU. 1 is required for the development of IL-9-producing T\u00a0cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","article-title":"Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells","volume":"33","author":"Staudt","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.iac.2017.01.001_bib45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1067\/mai.2003.1485","article-title":"Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes","volume":"111","author":"Erpenbeck","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"15","author":"Lambrect","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib47","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","article-title":"Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production","volume":"132","author":"Doherty","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ni.2045","article-title":"Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity","volume":"12","author":"Chang","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib50","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib51","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2017.01.001_bib52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2222.2008.03173.x","article-title":"Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors","volume":"39","author":"Bochner","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2017.01.001_bib54","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators\u2014a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2017.01.001_bib55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-4419-9533-9_13","article-title":"Mast cells in lung inflammation","volume":"716","author":"Moiseeva","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.iac.2017.01.001_bib56","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0091-6749(91)90158-K","article-title":"Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway","volume":"88","author":"Broide","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib57","first-page":"316049","article-title":"Mechanisms of remodeling in asthmatic airways","volume":"2012","author":"Shifren","year":"2012","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.iac.2017.01.001_bib58","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.iac.2017.01.001_bib59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1067\/mai.2001.111928","article-title":"Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis","volume":"107","author":"Hoshino","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2017.01.001_bib60","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","article-title":"Eosinophil-associated TGF-\u03b21 mRNA expression and airways fibrosis in bronchial asthma","volume":"17","author":"Minshall","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2017.01.001_bib61","first-page":"39","article-title":"Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma","volume":"79","author":"Mautino","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.iac.2017.01.001_bib62","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2017.01.001_bib63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iac.2017.01.001_bib64","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iac.2017.01.001_bib65","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2017.01.001_bib66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2017.01.001_bib67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1465-9921-14-93","article-title":"A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma","volume":"14","author":"Oh","year":"2013","journal-title":"Respiratoratory Research"},{"key":"10.1016\/j.iac.2017.01.001_bib68","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iac.2017.01.001_bib69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pupt.2015.03.003","article-title":"Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment","volume":"32","author":"Hall","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"issue":"188","key":"10.1016\/j.iac.2017.01.001_bib70","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"1","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2017.01.001_bib71","doi-asserted-by":"publisher","first-page":"e007709","DOI":"10.1136\/bmjopen-2015-007709","article-title":"Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma","volume":"6","author":"Molfino","year":"2016","journal-title":"BMJ Open"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856117300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T04:22:39Z","timestamp":1658722959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856117300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889856117300012"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2017.01.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory Disorders Associated with Allergy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}